Randomised clinical trial: a placebo‐controlled study of intravenous golimumab induction therapy for ulcerative colitisP. Rutgeerts, Brian G. Feagan, Colleen Marano et al.|Alimentary Pharmacology & Therapeutics|2015Cited by 86
Pharmacokinetics of Infliximab in Children with Moderate-to-Severe Ulcerative ColitisOmoniyi J. Adedokun, Jeffrey S. Hyams, Zhenhua Xu et al.|Inflammatory Bowel Diseases|2013Cited by 83
Maintenance of Efficacy and Continuing Safety of Golimumab for Active Ulcerative Colitis: PURSUIT-SC Maintenance Study Extension Through 1 YearWalter Reinisch, Brian G. Feagan, William J. Sandborn et al.|Clinical and Translational Gastroenterology|2016Cited by 40
Long-Term Benefit of Golimumab for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the PURSUIT-Maintenance ExtensionWalter Reinisch, Colleen Marano, William J. Sandborn et al.|Journal of Crohn s and Colitis|2018Cited by 35
OP009 Long-term safety and efficacy of golimumab in patients with moderately to severely active ulcerative colitis: Results from the PURSUIT-SC Maintenance study extensionWalter Reinisch, P. Rutgeerts, Peter G. Gibson et al.|Journal of Crohn s and Colitis|2014Cited by 2